A Phase II Study To Determine The Anti-Leukemic Effects Of STI571 In Combination With Ara-C In Patients With Chronic Myelogenous Leukemia In Chronic Phase
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Imatinib (Primary) ; Cytarabine
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 25 Jul 2011 Status changed to discontinued.
- 12 May 2009 Additional lead trial centre (Oregon Health and Science University), investigator(Druker BJ) added as reported by ClinicalTrials.gov.
- 22 Aug 2006 Status change